XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Series F Preferred Stock
Preferred Stock
Series F Preferred Stock
Common Stock
Treasury Stock
Additional Paid-In Capital
Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2021       2,070,861      
Treasury stock, beginning balance (in shares) at Dec. 31, 2021         7,553    
Beginning balance at Dec. 31, 2021 $ 25,497,000     $ 0 $ (181,000) $ 227,584,000 $ (201,906,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (4,539,000)           (4,539,000)
Stock-based compensation 52,000         52,000  
Forfeiture of unvested stock options (84,000)         (84,000)  
Common stock, ending balance (in shares) at Mar. 31, 2022       2,070,861      
Treasury stock, ending balance (in shares) at Mar. 31, 2022         7,553    
Ending balance at Mar. 31, 2022 20,926,000     $ 0 $ (181,000) 227,552,000 (206,445,000)
Common stock, beginning balance (in shares) at Dec. 31, 2021       2,070,861      
Treasury stock, beginning balance (in shares) at Dec. 31, 2021         7,553    
Beginning balance at Dec. 31, 2021 25,497,000     $ 0 $ (181,000) 227,584,000 (201,906,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (20,724,000)            
Series F Preferred Stock dividends 0            
Treasury stock, ending balance (in shares) at Sep. 30, 2022         7,553    
Ending balance at Sep. 30, 2022 4,803,000     $ 0 $ (181,000) 227,614,000 (222,630,000)
Common stock, beginning balance (in shares) at Mar. 31, 2022       2,070,861      
Treasury stock, beginning balance (in shares) at Mar. 31, 2022         7,553    
Beginning balance at Mar. 31, 2022 20,926,000     $ 0 $ (181,000) 227,552,000 (206,445,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (9,033,000)           (9,033,000)
Stock-based compensation 31,000         31,000  
Common stock, ending balance (in shares) at Jun. 30, 2022       2,070,861      
Treasury stock, ending balance (in shares) at Jun. 30, 2022         7,553    
Ending balance at Jun. 30, 2022 11,924,000     $ 0 $ (181,000) 227,583,000 (215,478,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (7,152,000)           (7,152,000)
Stock-based compensation 31,000         31,000  
Treasury stock, ending balance (in shares) at Sep. 30, 2022         7,553    
Ending balance at Sep. 30, 2022 $ 4,803,000     $ 0 $ (181,000) 227,614,000 (222,630,000)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022 0   0        
Common stock, beginning balance (in shares) at Dec. 31, 2022 2,070,861     2,070,861      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 7,553       7,553    
Beginning balance at Dec. 31, 2022 $ 3,617,000   $ 0 $ 0 $ (181,000) 227,645,000 (223,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (1,219,000)           (1,219,000)
Stock-based compensation 31,000         31,000  
Proceeds from private placement, net of fees and amounts held in escrow (in shares)     6,550        
Proceeds from private placement, net of fees and amounts held in escrow 1,473,000         1,473,000  
Preferred stock, ending balance (in shares) at Mar. 31, 2023     6,550        
Common stock, ending balance (in shares) at Mar. 31, 2023       2,070,861      
Treasury stock, ending balance (in shares) at Mar. 31, 2023         7,553    
Ending balance at Mar. 31, 2023 $ 3,902,000   $ 0 $ 0 $ (181,000) 229,149,000 (225,066,000)
Preferred stock, beginning balance (in shares) at Dec. 31, 2022 0   0        
Common stock, beginning balance (in shares) at Dec. 31, 2022 2,070,861     2,070,861      
Treasury stock, beginning balance (in shares) at Dec. 31, 2022 7,553       7,553    
Beginning balance at Dec. 31, 2022 $ 3,617,000   $ 0 $ 0 $ (181,000) 227,645,000 (223,847,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (3,163,000)            
Stock-based compensation (in shares)       179,535      
Common stock exchanged for pre-funded warrants (in shares)       (406,776)      
Conversions of Series F Preferred Stock (in shares)       2,111,337      
Series F Preferred Stock dividends $ (282,000)            
Preferred stock, ending balance (in shares) at Sep. 30, 2023 5,146 5,146 5,146        
Common stock, ending balance (in shares) at Sep. 30, 2023 4,294,455     4,294,455      
Treasury stock, ending balance (in shares) at Sep. 30, 2023 7,553     7,553 7,553    
Ending balance at Sep. 30, 2023 $ 6,661,000   $ 0 $ 0 $ (181,000) 233,852,000 (227,010,000)
Preferred stock, beginning balance (in shares) at Mar. 31, 2023     6,550        
Common stock, beginning balance (in shares) at Mar. 31, 2023       2,070,861      
Treasury stock, beginning balance (in shares) at Mar. 31, 2023         7,553    
Beginning balance at Mar. 31, 2023 3,902,000   $ 0 $ 0 $ (181,000) 229,149,000 (225,066,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (1,049,000)           (1,049,000)
Stock-based compensation (in shares)       179,535      
Stock-based compensation 411,000         411,000  
Warrant exercise, net of fees (in shares)       339,498      
Warrant exercise, net of fees 534,000         534,000  
Release of escrow from March 2023 private placement 4,000,000         4,000,000  
Fees associated with Series F Preferred Stock issuance (38,000)         (38,000)  
Conversions of Series F Preferred Stock (in shares)     (175) 146,587      
Conversions of Series F Preferred Stock 4,000         4,000  
Series F Preferred Stock dividends (149,000) $ (148,744)       (149,000)  
Preferred stock, ending balance (in shares) at Jun. 30, 2023   6,375 6,375        
Common stock, ending balance (in shares) at Jun. 30, 2023       2,736,481      
Treasury stock, ending balance (in shares) at Jun. 30, 2023         7,553    
Ending balance at Jun. 30, 2023 7,615,000   $ 0 $ 0 $ (181,000) 233,911,000 (226,115,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net loss (895,000)           (895,000)
Stock-based compensation 31,000         31,000  
Common stock exchanged for pre-funded warrants (in shares)       (406,776)      
Conversions of Series F Preferred Stock (in shares)     (1,229) 1,964,750      
Conversions of Series F Preferred Stock 43,000         43,000  
Series F Preferred Stock dividends $ (133,000) $ (133,364)       (133,000)  
Preferred stock, ending balance (in shares) at Sep. 30, 2023 5,146 5,146 5,146        
Common stock, ending balance (in shares) at Sep. 30, 2023 4,294,455     4,294,455      
Treasury stock, ending balance (in shares) at Sep. 30, 2023 7,553     7,553 7,553    
Ending balance at Sep. 30, 2023 $ 6,661,000   $ 0 $ 0 $ (181,000) $ 233,852,000 $ (227,010,000)